<address id="3xt9h"></address>
Explore the latest in pulmonary medicine, including recent guidelines and advances in management of asthma, COPD, pneumonia, and more.
This survey study assesses the acceptability of coronavirus disease 2019 (COVID-19) vaccine mandates among members of the US public.
This cohort study assesses outcomes from early tracheostomy in the airway management of patients with COVID-19 requiring mechanical ventilation.
This cohort study uses data from the French National Health Data System to assess the decline in the use of intravitreal anti–vascular endothelial growth factors before, during, and after pandemic-associated lockdown periods.
This case report describes a patient with coronavirus disease 2019 who experienced severe ocular neuropathy with panuveitis, resulting in permanent loss of visual acuity.
This randomized clinical trial examines whether prophylactic azithromycin is effective in preventing worsening of lung function and in reducing acute respiratory exacerbations in children with HIV-associated chronic lung disease taking antiretroviral therapy.
This Viewpoint discusses individual- and system-level barriers and solutions for people with serious mental illness to access coronavirus disease 2019 vaccination when it is available.
This Viewpoint discusses 4 factors that explain transmission risk during aerosol-generating medical procedures.
This study describes reasons for readmission, use of ICU interventions during readmission, and proportions of death after initial hospital discharge of COVID-19 patients from US Veterans Affairs (VA) hospitals March-June 2020.
This systematic review and meta-analysis examines evidence for household transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), disaggregated by several covariates, and compares it with other coronaviruses
This Medical Letter review summarizes the evidence underlying the US Food and Drug Administration’s emergency use authorization of bamlanivimab, an investigational neutralizing IgG1 monoclonal antibody for treatment of COVID-19, including specification of high-risk patient groups eligible for the drug and its dosage and administration.
This diagnostic study describes an online tool created with actual severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus copy number data to help policy makers understand how pooled testing compares with single-sample testing in different populations.
This cohort study investigates the prevalence by sex, age, and symptom severity of long-term lung, eye, and skin complications among survivors exposed to sulfur mustard between 1980 and 1988 during the Iran-Iraq War.
This cohort study characterizes patients with coronavirus disease 2019 (COVID-19) who were treated in US hospitals and examines risks factors associated with in-hospital mortality.
This survey study assesses attitudes of the German public regarding COVID-19 health communications with varying degrees of scientific uncertainty.
This randomized trial assesses whether a lower positive end-expiratory pressure (PEEP) of 0 to 5 cm H2O is noninferior to a higher PEEP (8 cm H2O) regarding number of ventilator-free days at day 28 among critically ill patients without acute respiratory distress syndrome.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: